• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VALERITAS, LLC. V-GO DISPOSABLE INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VALERITAS, LLC. V-GO DISPOSABLE INSULIN DELIVERY DEVICE Back to Search Results
Model Number V-GO 40
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Abscess (1690); Erythema (1840); Pain (1994)
Event Date 07/18/2014
Event Type  Injury  
Event Description
It was reported to valeritas customer care that diabetic patient (pt).Type 2 using the v-go 40 since (b)(6) 2014 experienced an abscess on his abdomen while using the v-go.According to the valeritas adverse event (ae) assessor, the patient stated that on (b)(6)2014, he removed the v-go from his left abdominal area, noticed a red mark and after a few days the red mark became "much larger, was hot, hard and very painful to touch".Patient reports he went to the emergency room on (b)(6) 2014, the abscess was drained and packed.Patient was not hospitalized.Patient states the drainage is still continuing (patient was not able to describe drainage amount or color), the site is very red and tender, the size of silver dollar.Patient was given a prescription and instructed to start antibiotics immediately (name of antibiotic unknown by patient), however patient has not filled the antibiotic prescription and states he will not be able to start the antibiotic till (b)(6) 2014 due to financial reasons.Ae assessor instructed patient to contact his hcp right away to discuss with hcp that he has not started the antibiotic.Patient is currently off the v-go for financial reasons, he was not discontinued from v-go by hcp.
 
Manufacturer Narrative
This mdr is being submitted per our procedure.Patient experienced an adverse event in the form of an abscess (on abdomen) at application site.Patient went to the emergency room where the abscess was drained and packed (medical intervention) to prevent further complications.The device was not available for investigation.Even though the v-go is terminally sterilized, there is always the possibility of infection at the application site and site preparation.Diabetics are also prone to infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
V-GO DISPOSABLE INSULIN DELIVERY DEVICE
Type of Device
V-GO
Manufacturer (Section D)
VALERITAS, LLC.
750 route 202 south
suite 100
bridgewater NJ 08807 2597
MDR Report Key4036900
MDR Text Key4726007
Report Number1226572-2014-00008
Device Sequence Number1
Product Code KZE
Combination Product (y/n)N
PMA/PMN Number
K103825
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Type of Report Initial,Followup
Report Date 07/25/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberV-GO 40
Device Lot NumberUNKNOWN
Date Manufacturer Received07/25/2014
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient Weight102
-
-